| Literature DB >> 24128663 |
Marilena Raciti1, Marilena Granzotto, Minh Do Duc, Cristina Fimiani, Giada Cellot, Enrico Cherubini, Antonello Mallamaci.
Abstract
In this study, we assayed the capability of four genes implicated in embryonic specification of the cortico-cerebral field, Foxg1, Pax6, Emx2 and Lhx2, to reprogramme mouse embryonic fibroblasts towards neural identities. Lentivirus-mediated, TetON-dependent overexpression of Pax6 and Foxg1 transgenes specifically activated the neural stem cell (NSC) reporter Sox1-EGFP in a substantial fraction of engineered cells. The efficiency of this process was enhanced up to ten times by simultaneous inactivation of Trp53 and co-administration of a specific drug mix inhibiting HDACs, H3K27-HMTase and H3K4m2-demethylase. Remarkably, a fraction of the reprogrammed population expressed other NSC markers and retained its new identity, even after switching off the reprogramming transgenes. When transferred into a pro-differentiative environment, Pax6/Foxg1-overexpressing cells activated the neuronal marker Tau-EGFP. Frequency of Tau-EGFP positive cells was almost doubled upon delayed delivery of Emx2 and Lhx2 transgenes. A further improvement of the neuron-like cell output was achieved by inhibition of the BMP and TGFβ pathways. Tau-EGFP positive cells were able to generate action potentials upon injection of depolarizing current pulses, further indicating their neuron-like phenotype.Entities:
Keywords: (allylamino)-17-demethoxygeldanamycin; 17AAD; Bmp; Bone Morphogenetic Protein; Cerebral cortex; FL; FPEL; FPL; FPd; Fibroblasts reprogramming; Foxg1; Foxg1-Lhx2; Foxg1-Pax6- Lhx2; Foxg1-Pax6-Emx2-Lhx2; Foxg1-Pax6-drugs; HDAC; HMT; MEF; NPC; NSC; Neural stem cells; Neuronal differentiation; PL; Pax6; Pax6-Lhx2; RMP; TF; Tgfb; Transforming Growth Factor b; VPA; histone deacetylase; histone methyltransferase; iPSC; induced pluripotent stem cell; moi; mouse embryonic fibroblast; multiplicity of infection; neural precursor cell; neural stem cell; resting membrane potential; t2PCPA; trans-2-Phenyl-cyclopropylamine hydrochloride; transcription factor; valproic acid
Mesh:
Substances:
Year: 2013 PMID: 24128663 DOI: 10.1016/j.mcn.2013.10.004
Source DB: PubMed Journal: Mol Cell Neurosci ISSN: 1044-7431 Impact factor: 4.314